FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3124678683> ?p ?o ?g. }

• W3124678683 endingPage "191" @default.
• W3124678683 startingPage "181" @default.
• W3124678683 abstract "<b><i>Objectives:</i></b> We developed the first German evidence- and consensus-based clinical guideline on diagnosis, treatment, and follow-up of germ cell tumours (GCT) of the testes in adult patients. We present the guideline content in 2 separate publications. The present second part summarizes the<b><i></i></b>recommendations for the treatment of advanced disease stages and for the management of follow-up and late effects. <b><i>Materials and Methods:</i></b> An interdisciplinary panel of 42 experts including 1 patient representative developed the guideline content. Clinical recommendations and statements were based on scientific evidence and expert consensus. For this purpose, evidence tables for several review questions, which were based on systematic literature searches (last search in March 2018), were provided. Thirty-one experts, who were entitled to vote, rated the final clinical recommendations and statements. <b><i>Results:</i></b> Here we present the treatment recommendations separately for patients with metastatic seminoma and non-seminomatous GCT (stages IIA/B and IIC/III), for restaging and treatment of residual masses, and for relapsed and refractory disease stages. The recommendations also cover extragonadal and sex cord/stromal tumours, the management of follow-up and toxicity, quality-of-life aspects, palliative care, and supportive therapy. <b><i>Conclusion:</i></b> Physicians and other medical service providers who are involved in the diagnostics, treatment, and follow-up of GCT (all stages, outpatient and inpatient care as well as rehabilitation) are the users of the present guideline. The guideline also comprises quality indicators for measuring the implementation of the guideline recommendations in routine clinical care; these data will be presented in a future publication." @default.
• W3124678683 created "2021-02-01" @default.
• W3124678683 creator A5000033879 @default.
• W3124678683 creator A5010990966 @default.
• W3124678683 creator A5011305627 @default.
• W3124678683 creator A5013173067 @default.
• W3124678683 creator A5015188002 @default.
• W3124678683 creator A5016611062 @default.
• W3124678683 creator A5017446958 @default.
• W3124678683 creator A5017462100 @default.
• W3124678683 creator A5019298885 @default.
• W3124678683 creator A5022166873 @default.
• W3124678683 creator A5026847363 @default.
• W3124678683 creator A5027659301 @default.
• W3124678683 creator A5028229965 @default.
• W3124678683 creator A5029130844 @default.
• W3124678683 creator A5037481591 @default.
• W3124678683 creator A5037991045 @default.
• W3124678683 creator A5039851740 @default.
• W3124678683 creator A5042221345 @default.
• W3124678683 creator A5045023567 @default.
• W3124678683 creator A5046782343 @default.
• W3124678683 creator A5048118430 @default.
• W3124678683 creator A5051003180 @default.
• W3124678683 creator A5051124421 @default.
• W3124678683 creator A5053148625 @default.
• W3124678683 creator A5054665574 @default.
• W3124678683 creator A5055275116 @default.
• W3124678683 creator A5056831189 @default.
• W3124678683 creator A5057695413 @default.
• W3124678683 creator A5059145325 @default.
• W3124678683 creator A5060326878 @default.
• W3124678683 creator A5061473230 @default.
• W3124678683 creator A5061889546 @default.
• W3124678683 creator A5061902489 @default.
• W3124678683 creator A5064834423 @default.
• W3124678683 creator A5065027287 @default.
• W3124678683 creator A5067287697 @default.
• W3124678683 creator A5068364488 @default.
• W3124678683 creator A5068423096 @default.
• W3124678683 creator A5074802220 @default.
• W3124678683 creator A5075155205 @default.
• W3124678683 creator A5075228549 @default.
• W3124678683 creator A5076463194 @default.
• W3124678683 creator A5077491941 @default.
• W3124678683 creator A5078383767 @default.
• W3124678683 creator A5080716302 @default.
• W3124678683 creator A5082055973 @default.
• W3124678683 creator A5082506567 @default.
• W3124678683 creator A5086182607 @default.
• W3124678683 creator A5086393240 @default.
• W3124678683 creator A5088519516 @default.
• W3124678683 creator A5089453974 @default.
• W3124678683 creator A5089838793 @default.
• W3124678683 date "2021-01-01" @default.
• W3124678683 modified "2023-10-16" @default.
• W3124678683 title "Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II – Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy" @default.
• W3124678683 doi "https://doi.org/10.1159/000511245" @default.
• W3124678683 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8006578" @default.
• W3124678683 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33486494" @default.
• W3124678683 hasPublicationYear "2021" @default.
• W3124678683 type Work @default.
• W3124678683 sameAs 3124678683 @default.
• W3124678683 citedByCount "16" @default.
• W3124678683 countsByYear W31246786832021 @default.
• W3124678683 countsByYear W31246786832022 @default.
• W3124678683 countsByYear W31246786832023 @default.
• W3124678683 crossrefType "journal-article" @default.
• W3124678683 hasAuthorship W3124678683A5000033879 @default.
• W3124678683 hasAuthorship W3124678683A5010990966 @default.
• W3124678683 hasAuthorship W3124678683A5011305627 @default.
• W3124678683 hasAuthorship W3124678683A5013173067 @default.
• W3124678683 hasAuthorship W3124678683A5015188002 @default.
• W3124678683 hasAuthorship W3124678683A5016611062 @default.
• W3124678683 hasAuthorship W3124678683A5017446958 @default.
• W3124678683 hasAuthorship W3124678683A5017462100 @default.
• W3124678683 hasAuthorship W3124678683A5019298885 @default.
• W3124678683 hasAuthorship W3124678683A5022166873 @default.
• W3124678683 hasAuthorship W3124678683A5026847363 @default.
• W3124678683 hasAuthorship W3124678683A5027659301 @default.
• W3124678683 hasAuthorship W3124678683A5028229965 @default.
• W3124678683 hasAuthorship W3124678683A5029130844 @default.
• W3124678683 hasAuthorship W3124678683A5037481591 @default.
• W3124678683 hasAuthorship W3124678683A5037991045 @default.
• W3124678683 hasAuthorship W3124678683A5039851740 @default.
• W3124678683 hasAuthorship W3124678683A5042221345 @default.
• W3124678683 hasAuthorship W3124678683A5045023567 @default.
• W3124678683 hasAuthorship W3124678683A5046782343 @default.
• W3124678683 hasAuthorship W3124678683A5048118430 @default.
• W3124678683 hasAuthorship W3124678683A5051003180 @default.
• W3124678683 hasAuthorship W3124678683A5051124421 @default.
• W3124678683 hasAuthorship W3124678683A5053148625 @default.
• W3124678683 hasAuthorship W3124678683A5054665574 @default.
• W3124678683 hasAuthorship W3124678683A5055275116 @default.
• W3124678683 hasAuthorship W3124678683A5056831189 @default.
• W3124678683 hasAuthorship W3124678683A5057695413 @default.
• W3124678683 hasAuthorship W3124678683A5059145325 @default.
• W3124678683 hasAuthorship W3124678683A5060326878 @default.

• next